乳腺癌患者初次全髋与全膝关节置换术后并发症风险是否增加
本研究基于关节登记系统,将423例有乳腺癌病史的初次全髋置换患者和540例初次全膝关节置换患者按1:1匹配非乳腺癌对照,评估死亡率、假体生存和并发症。结果显示乳腺癌患者全髋置换后无任何并发症生存率显著更低(91% vs 96%,HR=2,95%CI 1.1-3.4,p=0.017),全膝置换后并发症无显著差异;假体生存和功能评分改善两组相似。
要点
- 乳腺癌患者全髋置换后无并发症生存率低于对照(91% vs 96%,HR=2,95%CI 1.1-3.4,p=0.017)。
- 全髋置换后术中骨折发生率2.4% vs 1.4%,静脉血栓栓塞症1.4% vs 0.5%(乳腺癌 vs 对照)。
- 全膝置换后任何并发症无显著差异(p≥0.323),假体生存和功能评分改善两组相似。
核心结论
- 乳腺癌幸存者初次全髋和全膝置换后死亡或再手术风险未显著增加,但全髋置换后并发症风险增加两倍,包括术中骨折和静脉血栓栓塞症。
研究设计与样本
- 基于总关节登记系统识别有乳腺癌病史的初次全髋置换患者423例和全膝置换患者540例,按年龄、性别、BMI、手术类型和手术年份1:1匹配非乳腺癌对照。
- 采用Kaplan-Meier法评估死亡率、假体生存和并发症,采用Harris髋关节评分或膝关节学会评分评估临床结局,平均随访6年(2至15年)。
主要发现
- 乳腺癌患者全髋置换后5年生存率为92%(95%CI 89%-95%),全膝置换后为94%(95%CI 92%-97%)。
- 乳腺癌与非乳腺癌患者全髋置换后无任何再手术或翻修的5年假体生存相似(p≥0.412),全膝置换后亦相似(p≥0.271)。
- 乳腺癌患者全髋置换后无任何并发症生存率显著更低(91% vs 96%,HR=2,95%CI 1.1-3.4,p=0.017);全髋置换后术中骨折发生率为2.4% vs 1.4%,静脉血栓栓塞症为1.4% vs 0.5%(乳腺癌 vs 对照)。
- 全膝置换后任何并发症无显著差异(p≥0.323)。
- 乳腺癌与非乳腺癌患者Harris髋关节评分改善相似(p=0.514),膝关节学会评分改善相似(p=0.132)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Breast cancer survivors have known risk factors that might influence the results of total hip arthroplasty (THA) or total knee arthroplasty (TKA). This study evaluated clinical outcomes of patients with breast cancer history after primary THA and TKA. METHODS: Our total joint registry identified patients with breast cancer history undergoing primary THA (n = 423) and TKA (n = 540). Patients were matched 1:1 based upon age, sex, BMI, procedure (hip or knee), and surgical year to non-breast cancer controls. Mortality, implant survival, and complications were assessed via Kaplan-Meier methods. Clinical outcomes were evaluated via Harris Hip Scores (HHSs) or Knee Society Scores (KSSs). Mean follow-up was six years (2 to 15). RESULTS: Breast cancer patient survival at five years was 92% (95% confidence interval (CI) 89% to 95%) after THA and 94% (95% CI 92% to 97%) after TKA. Breast and non-breast cancer patients had similar five-year implant survival free of any reoperation or revision after THA (p ≥ 0.412) and TKA (p ≥ 0.271). Breast cancer patients demonstrated significantly lower survival free of any complications after THA (91% vs 96%, respectively; hazard ratio = 2 (95% CI 1.1 to 3.4); p = 0.017). Specifically, the rate of intraoperative fracture was 2.4% vs 1.4%, and venous thromboembolism (VTE) was 1.4% and 0.5% for breast cancer and controls, respectively, after THA. No significant difference was noted in any complications after TKA (p ≥ 0.323). Both breast and non-breast cancer patients experienced similar improvements in HHSs (p = 0.514) and KSSs (p = 0.132). CONCLUSION: Breast cancer survivors did not have a significantly increased risk of mortality or reoperation after primary THA and TKA. However, there was a two-fold increased risk of complications after THA, including intraoperative fracture and VTE.
引用
- Ledford CK, Shirley MB, Spangehl MJ, et al. Do breast cancer patients have increased risk of complications after primary total hip and total knee arthroplasty? Bone Joint J. 2024. PMID: 38555948. doi:10.1302/0301-620X.106B4.BJJ-2023-0968.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。